Dexamethasone-Moxifloxacin- Ketorolac — Class II drug recall D-0514-2024
Ongoing recall by Imprimis NJOF, LLC, reported 2024-06-05, distributed nationwide. Lack of Assurance of Sterility
| Recall number | D-0514-2024 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Imprimis NJOF, LLC, Ledgewood, NJ, United States |
| Recall initiated | 2024-05-14 |
| Classified | 2024-05-29 |
| Reported by FDA | 2024-06-05 |
| Distributed | Nationwide (US) |
| Quantity | 38,060 vials |
| Reason classes | sterility |
| NDC | 71384-0513-01 |
| Lot numbers | 23MAY008, 23NOV035, 23OCT011, 24JAN024 |
| Expiration dates | 2024-05-01, 2024-10-26, 2024-12-06, 2025-01-14 |
Product
Dexamethasone-Moxifloxacin- Ketorolac (1mg/mL, 0.5 mg/mL and 0.4 mg/mL), Preservative-Free, 1mL Single-Use vials for Intraocular Injection, Rx only, Imprimis NJOF, LLC. 1705 Route 46 West, unit 6B, Ledgewood, NJ 07852, NDC 71384-513-01
Reason for recall
Lack of Assurance of Sterility
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0514-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.